Nonalcoholic fatty liver disease (NAFLD) is strongly associated with both atherosclerotic cardiovascular disease (CVD) and Fetuin-A. However, the association of Fetuin-A with atherosclerosis is more controversial. We hypothesized that the pathogenic interplay of NAFLD, Fetuin-A and atherosclerosis varies based on arterial site. Accordingly, we aimed to assess NAFLD prevalence, Fetuin-A values and their relationship with symptomatic atherosclerosis occurring in different localizations: coronary artery disease (CAD) vs. peripheral arterial disease (PAD)
BACKGROUND: Fetuin-A is a hepatic secretory protein that inhibits arterial calcification in vitro. T...
Background—Fetuin-A is a multifunctional hepatic secretory protein that inhibits the action of insul...
Evidence suggests a close connection between Nonalcoholic Fatty Liver Disease (NAFLD) and increased ...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with both atherosclerotic cardiovasc...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) patients are prone to coronary artery disease...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrom...
ObjectivesThe aim of this study was to determine the association of fetuin-A with subclinical cardio...
Background/Aims: Fetuin-A, a glycoprotein with anti-inflammatory properties, plays an important role...
Background: Nonalcoholic fatty liver disease (NAFLD), a feature of metabolic syndrome is a highly pr...
AimsFetuin-A is a hepatic secretory protein that both promotes insulin resistance and inhibits arter...
Non Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease in Western countr...
Background/Aims: Fatty liver is the hepatic component of the metabolic syndrome. Insulin resistance,...
Non-alcoholic fatty liver disease (NAFLD) refers to fatty infiltration of liver in the absence of si...
Purpose: The hepatokine fetuin-A might have a role as molecular link between non-alcoholic fatty liv...
BACKGROUND: Fetuin-A is a hepatic secretory protein that inhibits arterial calcification in vitro. T...
BACKGROUND: Fetuin-A is a hepatic secretory protein that inhibits arterial calcification in vitro. T...
Background—Fetuin-A is a multifunctional hepatic secretory protein that inhibits the action of insul...
Evidence suggests a close connection between Nonalcoholic Fatty Liver Disease (NAFLD) and increased ...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with both atherosclerotic cardiovasc...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) patients are prone to coronary artery disease...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrom...
ObjectivesThe aim of this study was to determine the association of fetuin-A with subclinical cardio...
Background/Aims: Fetuin-A, a glycoprotein with anti-inflammatory properties, plays an important role...
Background: Nonalcoholic fatty liver disease (NAFLD), a feature of metabolic syndrome is a highly pr...
AimsFetuin-A is a hepatic secretory protein that both promotes insulin resistance and inhibits arter...
Non Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease in Western countr...
Background/Aims: Fatty liver is the hepatic component of the metabolic syndrome. Insulin resistance,...
Non-alcoholic fatty liver disease (NAFLD) refers to fatty infiltration of liver in the absence of si...
Purpose: The hepatokine fetuin-A might have a role as molecular link between non-alcoholic fatty liv...
BACKGROUND: Fetuin-A is a hepatic secretory protein that inhibits arterial calcification in vitro. T...
BACKGROUND: Fetuin-A is a hepatic secretory protein that inhibits arterial calcification in vitro. T...
Background—Fetuin-A is a multifunctional hepatic secretory protein that inhibits the action of insul...
Evidence suggests a close connection between Nonalcoholic Fatty Liver Disease (NAFLD) and increased ...